Purchase Order 36C25526P0018
- Not listed
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Novocure Inc., a foreign-owned for-profit organization, to provide its Optune tumor treating fields (TTFields) delivery systems, transducer arrays, rentals, and support services to VA medical centers. This $126,000.00 order was placed by the VA VHA Veterans Integrated Service Network (VISN) 23 and is for services to be performed in Portsmouth, New Hampshire. Novocure is the...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded Novocure Inc., a foreign-owned for-profit organization, a firm fixed-price purchase order contract valued at $126,000.00. The contract is to provide Novocure's Optune Plus Transducer system, including device rentals and support services, for a period from November 11, 2021 to May 10, 2022. The order was issued by the VA's Veterans Integrated Service Network 15 (VISN 15) and will support the delivery of...
- Novocure Inc., a foreign-owned medical device manufacturer specializing in Tumor Treating Fields (TTFields) technology, was awarded a firm fixed-price purchase order by Veterans Integrated Service Network 12 on October 27, 2025, for the rental of cancer treatment devices to support immediate medical needs for veteran patients. The contract, valued at $49,748.73, calls for a three-month rental period with an ultimate completion date of January 27, 2026, and will be performed at the VA facility in...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Novocure Inc., a foreign-owned for-profit oncology company, for the rental of Optune Plus transducer arrays, a novel cancer treatment technology. The $126,000.00 order, placed by the VA VHA's Veterans Integrated Service Network (VISN) 15, is to provide the Optune TTFields therapy devices, transducers, rentals, and support services to VA medical facilities, including locations...
- This is a firm fixed price purchase order from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit company, to provide its Optune electrical field therapy transducers and related rental and support services. The contract, with a potential value of $105,000.00, has a completion date of September 30, 2020 and was awarded on May 1, 2020. The order is to deliver Novocure's Optune tumor treating fields (TTFields) therapy...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Novocure Inc., a foreign-owned for-profit organization, to provide its Optune tumor treating fields (TTFields) therapy devices, transducers, rentals, and support services. The $126,000.00 contract is for delivery of these medical technologies to VA facilities nationwide, including locations in Portsmouth, New Hampshire; San Antonio, Texas; Des Moines, Iowa; and others, to...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed-price purchase order to Novocure Inc., a foreign-owned, for-profit manufacturer, to provide its Optune Plus Transducers product line. The $16,582.91 contract, which does not have a set-aside designation, is part of Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) agreement with the VA VHA to deliver its Tumor Treating Fields (TTFields) cancer therapy devices, transducer arrays,...
- The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a $49,748.73 firm-fixed-price delivery order contract to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, for the 3-month rental of Optune Plus transducers. Novocure's proprietary Tumor Treating Fields (TTFields) technology is FDA-approved for the treatment of glioblastoma and mesothelioma. This delivery order is issued under Novocure's 5-year Federal Supply Schedule (FSS)...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm-fixed-price purchase order contract to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, for the procurement of Optune Plus Transducers. The $33,165.82 contract has an ultimate completion date of November 14, 2023. This contract award is not set aside for any specific business category. Novocure is a manufacturer of the Optune line of Tumor Treating Fields (TTFields) therapy...
- The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $49,748.73 firm-fixed-price delivery order contract to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune Plus transducer devices, equipment rentals, and related support services to be delivered to a VA medical center in Portsmouth, New Hampshire. This delivery order is issued under Novocure's 5-year Federal Supply Schedule...
The Department of Veterans Affairs, Veterans Integrated Service Network 15 (VISN 15), awarded a $49,748.73 firm fixed-price purchase order to Novocure Inc. on October 30, 2025, for the rental of Optune Plus transducers. The contract, with an ultimate completion date of March 31, 2026, will be performed in Portsmouth, New Hampshire. Novocure Inc., a foreign-owned medical device manufacturer specializing in Tumor Treating Fields (TTFields) technology, will provide non-invasive cancer treatment equipment and associated support services to VA facilities. The award carries no set-aside designation, consistent with Novocure's historical contracting pattern with the VA, likely reflecting the specialized and proprietary nature of the technology. This purchase order is issued under Novocure's existing Federal Supply Schedule contract with the VA VHA Medical Equipment and Supplies category (FSS-65-II-A), a multiple-award vehicle valued at $28.85 million and effective through October 31, 2027. As the prime contractor, Novocure delivers its FDA-approved Optune medical devices directly to VA medical centers without employing subcontractors. Through this procurement vehicle and associated delivery orders, VA facilities nationwide can access Novocure's cutting-edge cancer treatment technologies to expand veterans' access to advanced therapeutic options for treating solid tumors, including glioblastoma and mesothelioma.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.7k | 10/30/25 |